Venkys (India) Ltd

- There is no mention of any current or future fundraising through debt or equity in the transcript. - The discussion primarily focuses on operational performance, market share, feed costs, and expansion plans such as the new AHP plant. - Capex plans mentioned include Rs.35 Crores initial investment and another Rs.12-15 Crores in phase 2 for the AHP unit, but no specific details on raising funds for these. - The management did not indicate any intention or plan for equity or debt fundraising during the call.

- Venky’s India Limited is setting up a second unit under its Animal Health Products (AHP) segment. - Initial capital investment for the new AHP plant (Phase-1) is Rs. 35 Crores. - Phase-2 will involve an additional Rs. 12 to 15 Crores investment. - The expansion project is expected to be completed by November-December 2022. - The new AHP unit is anticipated to generate around 30% additional revenue in Phase-1. - Revenues from the AHP expansion are expected to impact FY2023-24. - The new plant targets specialized areas such as feed safety, nutritional supplements, and natural products to enhance bottom-line growth.

- Poultry business is expected to grow around 20% annually, supported by stable feed prices and easing raw material costs. - Animal Health Products (AHP) segment growth projected at around 34%, driven by the new AHP plant becoming operational by end FY2022 and ramping up in FY2023-24. - AHP expansion is expected to add approximately 30% additional revenue in phase-1 after plant completion. - Focus on specialized products within AHP like feed safety, nutritional supplements, and natural products will contribute to positive growth and better margins. - Processed food division anticipates around 25% annual growth, largely fueled by QSR (Quick Service Restaurant) partnerships and new retail store openings. - The overall company sales turnover witnessed 40% growth in FY2022; similar momentum is targeted through product diversification and market expansion. - Stability in input prices and improved consumer acceptance of higher product prices expected to support volume growth.

- Venky’s expects continued revenue growth, especially in the Poultry and Animal Health Products (AHP) segments. - Poultry business growth projected around 20% year-on-year. - AHP segment expected to grow over 30%, aided by a new plant coming online, expanding capacity, and specialization. - Improvement in profitability anticipated due to stabilizing feed costs, especially a 10% relief in soya prices compared to the previous year. - Margin improvement likely as broiler bird prices stabilize above Rs.100, supported by better consumer acceptance. - Feed cost pressure from raw materials like soya and maize is expected to ease, improving margins. - New AHP plant Phase-1 capex of Rs.35 Crores expected to add about 30% additional revenue in the medium term. - FY2023 expected to show relief in profitability compared to FY2022, which had abnormal cost inflation. - Market share gains seen as potentially temporary, with caution on long-term retention.

The transcript does not explicitly mention the current or expected order book or pending orders for Venky’s India Limited. However, from the discussion: - The company is expanding its Animal Health Products (AHP) segment with a new plant expected to be completed by Nov-Dec 2022, indicating expected future capacity and potential order growth. - Venky’s is working on increasing exports to the UAE under the new FTA agreement, targeting completely processed chicken products, suggesting expected export order inflows. - There is mention of growing sales with QSR (Quick Service Restaurants) partners, who are expanding retail outlets, implying a growing demand pipeline. - The management is optimistic about market conditions improving in FY2023 with relief in raw material prices and stable broiler prices, potentially leading to better order flow. No concrete order book figures or pending order quantities were disclosed in the call.